The Stanford Parkinson's Disease Plasma Study
NCT02968433
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease(PD)
Interventions
DRUG:
Infusions of young plasma
Sponsor
Stanford University